rs371465585

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_002458.3(MUC5B):​c.845C>A​(p.Ala282Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000559 in 1,534,066 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 17/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A282V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00022 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00060 ( 1 hom. )

Consequence

MUC5B
NM_002458.3 missense

Scores

18

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:1

Conservation

PhyloP100: -0.0240

Publications

0 publications found
Variant links:
Genes affected
MUC5B (HGNC:7516): (mucin 5B, oligomeric mucus/gel-forming) This gene encodes a member of the mucin family of proteins, which are highly glycosylated macromolecular components of mucus secretions. This family member is the major gel-forming mucin in mucus. It is a major contributor to the lubricating and viscoelastic properties of whole saliva, normal lung mucus and cervical mucus. This gene has been found to be up-regulated in some human diseases, including sinus mucosa of chronic rhinosinusitis (CRS), CRS with nasal polyposis, chronic obstructive pulmonary disease (COPD) and H. pylori-associated gastric disease, and it may be involved in the pathogenesis of these diseases. [provided by RefSeq, Jul 2010]
MUC5B Gene-Disease associations (from GenCC):
  • interstitial lung disease
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.08309758).
BP6
Variant 11-1228634-C-A is Benign according to our data. Variant chr11-1228634-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 504730.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MUC5BNM_002458.3 linkc.845C>A p.Ala282Glu missense_variant Exon 8 of 49 ENST00000529681.5 NP_002449.2 Q9HC84

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MUC5BENST00000529681.5 linkc.845C>A p.Ala282Glu missense_variant Exon 8 of 49 5 NM_002458.3 ENSP00000436812.1 Q9HC84
MUC5BENST00000525715.5 linkn.903C>A non_coding_transcript_exon_variant Exon 8 of 26 1
MUC5BENST00000531082.1 linkn.115C>A non_coding_transcript_exon_variant Exon 1 of 3 3

Frequencies

GnomAD3 genomes
AF:
0.000217
AC:
33
AN:
152200
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000523
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000294
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000243
AC:
33
AN:
135968
AF XY:
0.000231
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000327
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000474
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000596
AC:
824
AN:
1381866
Hom.:
1
Cov.:
32
AF XY:
0.000592
AC XY:
404
AN XY:
681948
show subpopulations
African (AFR)
AF:
0.0000635
AC:
2
AN:
31506
American (AMR)
AF:
0.000224
AC:
8
AN:
35658
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25136
East Asian (EAS)
AF:
0.0000280
AC:
1
AN:
35704
South Asian (SAS)
AF:
0.0000126
AC:
1
AN:
79070
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
34752
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4098
European-Non Finnish (NFE)
AF:
0.000734
AC:
791
AN:
1078266
Other (OTH)
AF:
0.000364
AC:
21
AN:
57676
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.478
Heterozygous variant carriers
0
47
94
142
189
236
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000217
AC:
33
AN:
152200
Hom.:
0
Cov.:
34
AF XY:
0.000215
AC XY:
16
AN XY:
74354
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41456
American (AMR)
AF:
0.000523
AC:
8
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5192
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000294
AC:
20
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000308
Hom.:
0
Bravo
AF:
0.000310
TwinsUK
AF:
0.000270
AC:
1
ALSPAC
AF:
0.00104
AC:
4
ESP6500AA
AF:
0.000846
AC:
3
ESP6500EA
AF:
0.000139
AC:
1
ExAC
AF:
0.000105
AC:
6

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not specified Uncertain:1Benign:1
Feb 27, 2024
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.845C>A (p.A282E) alteration is located in exon 8 (coding exon 8) of the MUC5B gene. This alteration results from a C to A substitution at nucleotide position 845, causing the alanine (A) at amino acid position 282 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Apr 19, 2018
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The p.Ala282Glu variant in MUC5B was observed by our laboratory in the heterozyg ous state in 1 individual with pulmonary disease, but this individual also harbo red one pathogenic and one variant of uncertain significance in CFTR. This varia nt has been identified in 31/65026 European chromosomes by the Genome Aggregatio n Database (gnomAD, http://gnomad.broadinstitute.org/; dbSNP rs371465585). Alani ne (Ala) at position 282 is not conserved in mammals or evolutionarily distant s pecies and 6 species, including 2 mammals carry a glutamic acid (Glu) at this po sition, supporting that this change may be tolerated. In summary, the p.Ala282Gl u variant is likely benign based. ACMG/AMP Criteria applied: BP4, BP5. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.40
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
0.23
DANN
Benign
0.41
DEOGEN2
Benign
0.015
T
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.028
N
LIST_S2
Benign
0.069
T
M_CAP
Benign
0.035
D
MetaRNN
Benign
0.083
T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
0.43
N
PhyloP100
-0.024
PrimateAI
Benign
0.46
T
PROVEAN
Benign
-0.45
N
REVEL
Benign
0.16
Sift
Benign
1.0
T
Polyphen
0.0
B
Vest4
0.070
MVP
0.21
ClinPred
0.012
T
GERP RS
-6.8
Varity_R
0.059
gMVP
0.57
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.13
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs371465585; hg19: chr11-1249864; API